alexa Nathalie Seigneuret | Innovative Medicines Initiative
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Nathalie Seigneuret

Senior Scientific Project Manager
Innovative Medicines Initiative
Belgium

 
Biography

Nathalie is Senior Scientific Project Manager at IMI (Innovative Medicines Initiative) responsible for the coordination and management of projects within the scientific team. Having a regulatory background, liaison for regulatory matters. efore joining IMI in 2011, she was a scientific administrator at the European Medicines Agency (EMA) where she first gained experience in the centralised procedures and other activities related to the evaluation of marketing authorisation applications (mostly in relation to anti-infectives) and later on the paediatric development with the implementation of the EU Paediatric Regulation at the Agency level.

Research Interest

Regulatory affairs,Pharmacy, Translational Medicine.

Publications

Data Standards are Needed to Move Translational Medicine Forward

Ann Marie Martin, Nathalie Seigneuret, Ferran Sanz and Michel Goldman

Commentary: Transl Med 2013, 3: 119

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords